- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rituximab-placebo
Total 56416 results
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan
-
German High-Grade Non-Hodgkin's Lymphoma Study...Deutsche Krebshilfe e.V., Bonn (Germany)CompletedNon-Hodgkin's Lymphoma (NHL)Germany
-
CelltrionCompleted
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingPrimary Membranous NephropathyChina
-
University Hospital, ToursRecruiting
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Laida Cuevas PalomaresRecruiting
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Brazil, Slovenia, Spain, Germany, Switzerland, Russian Federation, Israel, Sweden, Albania, Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Colombia, Croatia, Ecuador, Egypt, Finland, Greece, Mexico, Romania, Slovakia, ...
-
University of California, DavisGenentech, Inc.CompletedPrimary Biliary CirrhosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Thrombocytopenic PurpuraAustralia
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Cedars-Sinai Medical CenterGenentech, Inc.; BiogenCompletedKidney TransplantUnited States
-
East Carolina UniversityGenentech, Inc.CompletedPulmonary Alveolar Proteinosis | Primary DiseaseUnited States
-
University College, LondonRoche Pharma AG; Cancer Research UKActive, not recruitingLymphomaNew Zealand, United Kingdom, Australia
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicSweden
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaGermany
-
Medical University of ViennaTerminated
-
Medical College of WisconsinWithdrawnGranulomatous and Lymphocytic Interstitial Lung Disease
-
Hoffmann-La RocheGenentech, Inc.CompletedPemphigus VulgarisUnited States, Spain, Israel, Australia, France, Argentina, Canada, Turkey, Germany, Brazil, Italy, Ukraine
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMALT LymphomaSwitzerland, Italy, France
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; The Research Council... and other collaboratorsCompletedChronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)Norway
-
University of WashingtonBayerTerminatedNon-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Wake Forest University Health SciencesCompletedMultiple SclerosisUnited States
-
M.D. Anderson Cancer CenterTerminatedLeukemia | Metastatic Malignant Neoplasm to the Leptomeninges | Lymphoid MalignanciesUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedRheumatoid ArthritisFinland
-
Hoffmann-La RocheCompleted
-
University of California, San FranciscoGenentech, Inc.CompletedRenal Transplant RejectionUnited States
-
Genentech, Inc.Seagen Inc.Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Lymphoproliferative DisorderUnited States
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Newly DiagnosedChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
CHU de ReimsUnknownIndolent Cutaneous B Cell LymphomasFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
SymBio PharmaceuticalsCompletedLow-grade B Cell Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not IndicatedJapan
-
Oslo University HospitalNorwegian Cancer Society; Helse Sor-OstCompletedFollicular LymphomaNorway
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Karolinska University HospitalCompleted
-
Lymphoma Study AssociationCompletedLymphomaFrance, Belgium
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedChronic Lymphocytic LeukemiaUnited States